GLP-1 agonist users had a 17% lower cancer risk compared to non-users in a large retrospective study. The reductions achieved ...

Serena Williams reveals her use of GLP-1, Zepbound and calls out the stigma surrounding the use of the popular weight loss ...

Serena Williams has been taking a GLP-1 medication to help with her recent weight loss, she revealed for the first time in an ...

Serena Williams has revealed she lost 31 pounds on the GLP-1 Zepbound: "I just couldn't get my weight to where I needed to be at a healthy place." ...

Tennis legend Serena Williams has sparked conversations around fitness and health after reports of her weight loss journey ...

But what is important to me is transparency.” That calling has led her to this very moment: Williams is ready to share that ...

Serena Williams shares she is now using a GLP-1 in partnership with Ro, a digital health care company. Find out why she’s not ...

The 23-time Grand Slam champion recently opened up to PEOPLE exclusively about using a GLP-1 medication to help with weight ...

Columnist Teri Sforza writes that studies have found that semaglutide reduced alcohol intake, binge drinking and relapse ...

Tricare officials said the Defense Health Agency is eliminating coverage for its Tricare for Life beneficiaries and others to "align with federal coverage requirements." ...

GLP-1 receptor agonists may outperform metformin in lowering the risk for dementia, particularly Alzheimer’s disease and other nonvascular types, in patients with type 2 diabetes.

GLP-1 receptor agonists show promise in treating hidradenitis suppurativa, offering significant symptom relief and improved ...